Detailed Information on Publication Record
2011
Assays for determination of matrix metalloproteinases and their activity
KŘÍZKOVÁ, Soňa, Ondřej ZÍTKA, Michal MASAŘÍK, Vojtěch ADAM, Marie STIBOROVÁ et. al.Basic information
Original name
Assays for determination of matrix metalloproteinases and their activity
Authors
KŘÍZKOVÁ, Soňa (203 Czech Republic, guarantor), Ondřej ZÍTKA (203 Czech Republic), Michal MASAŘÍK (203 Czech Republic, belonging to the institution), Vojtěch ADAM (203 Czech Republic), Marie STIBOROVÁ (203 Czech Republic), Tomáš ECKSCHLAGER (203 Czech Republic), Grace J. CHAVIS (840 United States of America) and René KIZEK (203 Czech Republic)
Edition
Trends in Analytical Chemistry, 2011, 0165-9936
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10406 Analytical chemistry
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 6.273
RIV identification code
RIV/00216224:14110/11:00056993
Organization unit
Faculty of Medicine
UT WoS
000298621500017
Keywords in English
Activity-based profiling; Cancer; Disease marker; Enzymatic method; Fluorimetric method; Immunochemical method; In-vivo imaging; Matrix metalloproteinase (MMP); Multiple-enzyme/multiple-reagent assay system (MEMRAS); Phage display
Tags
International impact
Změněno: 23/3/2012 13:55, Mgr. Michal Petr
Abstract
V originále
Matrix metalloproteinases (MMPs) are involved in many physiological and pathological processes. Due to their ability to cleave and to remodel components of surrounding tissues, MMPs may affect cell migration, differentiation, growth, inflammatory processes, neovascularization, wound healing, apoptosis, the uterine cycle and many other actions within the body, including those needed for tumorigenesis and other diseases. MMPs can therefore be used as potential markers for detecting various cancers, neurodegenerative, and immune and cardiovascular diseases. Numerous MMP assays were developed for clinical and research purposes, but far more attention has been devoted to understanding their biological functions. Due to differences in methodology, results obtained in various laboratory settings are difficult to compare because of the lack of standards and analyticalmethods of validation. Limits of detection of particularmethods used for identifyingMMPs are also disputable. Enzymatic, immunochemical and fluorimetric methods are particularly suitable for clinical use. In-vivo imaging methods offer many potential advantages in cancer research and diagnostics. Other methods are subject to investigation [e.g., phage display, multiple-enzyme/multiple-reagent assay system (MEMRAS) and activity-based profiling].
Links
NS10200, research and development project |
|